LEADER 01398nam  2200409Ia 450 
001 9910698896503321
005 20090504153758.0
035   $a(CKB)5470000002396896
035   $a(OCoLC)320129179
035   $a(EXLCZ)995470000002396896
100   $a20090504d2007      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $econsiderations for plasmid DNA vaccines for infectious disease indications
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2007]
215   $ai, 11 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 4, 2009).
300   $a"November 2007".
320   $aIncludes bibliographical references (pages 9-11).
517   $aGuidance for industry 
606   $aPlasmids$xGenetics
606   $aInfection
606   $aVaccines$zUnited States$xTesting
615  0$aPlasmids$xGenetics.
615  0$aInfection.
615  0$aVaccines$xTesting.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910698896503321
996   $aGuidance for industry$93434577
997   $aUNINA